Open access
3,566
Views
5
CrossRef citations to date
0
Altmetric
Hematology
A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab
Katharine Batta Department of Hematology and Medical Oncology, Wake Forest Baptist School of Medicine, Winston-Salem, NC, USA
https://orcid.org/0000-0003-3672-8741
Bob G. Schultzb Outcomes Research, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA
https://orcid.org/0000-0002-7023-8378
Jorge Caicedob Outcomes Research, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA
https://orcid.org/0000-0002-5816-568X
Christopher S. Hollenbeakc Department of Health Policy and Administration, The Pennsylvania State University, College of Health and Human Development, University Park, PA, USA
https://orcid.org/0000-0002-3362-814X
Neha Agrawald Complete HEOR Solutions, North Wales, PA, USA
https://orcid.org/0000-0002-1758-2786
Sagnik Chatterjeed Complete HEOR Solutions, North Wales, PA, USA
https://orcid.org/0000-0002-8800-7746
Michael Bullanob Outcomes Research, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USACorrespondence[email protected]
https://orcid.org/0000-0002-9961-4576
Pages 1685-1693
|
Received 24 Jun 2022, Accepted 19 Jul 2022, Published online: 03 Aug 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.